S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSEAMERICAN:ELMD

Electromed (ELMD) Stock Forecast, Price & News

$11.77
-0.47 (-3.84%)
(As of 06/9/2023 ET)
Compare
Today's Range
$11.76
$12.10
50-Day Range
$10.03
$13.60
52-Week Range
$8.75
$13.84
Volume
6,811 shs
Average Volume
13,219 shs
Market Capitalization
$100.75 million
P/E Ratio
42.04
Dividend Yield
N/A
Price Target
$20.50

Electromed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
74.2% Upside
$20.50 Price Target
Short Interest
Healthy
0.62% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of Electromed in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.98 out of 5 stars


ELMD stock logo

About Electromed (NYSEAMERICAN:ELMD) Stock

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Receive ELMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.

ELMD Stock News Headlines

Electromed appoints Jim Cunniff new CEO
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Electromed Names Jim Cunniff President, CEO
Electromed appoints CEO
Electromed (NYSE:ELMD) Raised to Strong-Buy at StockNews.com
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Recap: Electromed Q3 Earnings
Head to Head Review: Sonova (OTCMKTS:SONVY) vs. (NYSE:ELMD)
Electromed (NYSE:ELMD) Coverage Initiated at StockNews.com
Earnings Scheduled For February 14, 2023
Electromed's Earnings: A Preview
Electromed, Inc. (ELMD) Q1 2023 Earnings Call Transcript
See More Headlines

ELMD Price History

ELMD Company Calendar

Last Earnings
11/09/2021
Today
6/09/2023
Fiscal Year End
6/30/2023
Next Earnings (Estimated)
8/21/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:ELMD
Previous Symbol
NYSEMKT:ELMD
Employees
132
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$20.50
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$15.00
Forecasted Upside/Downside
+74.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$2.31 million
Pretax Margin
6.67%

Debt

Sales & Book Value

Annual Sales
$41.66 million
Cash Flow
$0.32 per share
Book Value
$4.00 per share

Miscellaneous

Free Float
7,508,000
Market Cap
$100.75 million
Optionable
Not Optionable
Beta
0.42

Key Executives

  • Kathleen S. Skarvan
    President, Chief Executive Officer & Director
  • Bradley M. Nagel
    CFO, CAO, Secretary & Treasurer
  • Christopher Holland
    Chief Commercial Officer
  • Kristine Owata
    Vice President-Reimbursement & Payer Relations
  • Diane M. Kaufman
    Vice President-Human Resources













ELMD Stock - Frequently Asked Questions

Should I buy or sell Electromed stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ELMD shares.
View ELMD analyst ratings
or view top-rated stocks.

What is Electromed's stock price forecast for 2023?

3 Wall Street research analysts have issued 12 month target prices for Electromed's shares. Their ELMD share price forecasts range from $15.00 to $26.00. On average, they predict the company's stock price to reach $20.50 in the next twelve months. This suggests a possible upside of 74.2% from the stock's current price.
View analysts price targets for ELMD
or view top-rated stocks among Wall Street analysts.

How have ELMD shares performed in 2023?

Electromed's stock was trading at $10.4350 at the beginning of 2023. Since then, ELMD stock has increased by 12.8% and is now trading at $11.77.
View the best growth stocks for 2023 here
.

Are investors shorting Electromed?

Electromed saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 39,900 shares, an increase of 12.1% from the April 15th total of 35,600 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 2.5 days. Currently, 0.6% of the shares of the company are sold short.
View Electromed's Short Interest
.

When is Electromed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our ELMD earnings forecast
.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSEAMERICAN:ELMD) announced its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by $0.01. The medical equipment provider had revenue of $10 million for the quarter, compared to analyst estimates of $9 million. Electromed had a net margin of 5.50% and a trailing twelve-month return on equity of 7.18%.

What other stocks do shareholders of Electromed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE).

What is Electromed's stock symbol?

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Who are Electromed's major shareholders?

Electromed's stock is owned by a number of retail and institutional investors. Top institutional investors include Punch & Associates Investment Management Inc. (4.91%), Dimensional Fund Advisors LP (3.27%), Hunter Associates Investment Management LLC (0.86%), Renaissance Technologies LLC (0.63%), Annex Advisory Services LLC (0.27%) and BlackRock Inc. (0.22%). Insiders that own company stock include A Jones Lee, Michael Joseph Maccourt and Stephen H Craney.
View institutional ownership trends
.

How do I buy shares of Electromed?

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Electromed's stock price today?

One share of ELMD stock can currently be purchased for approximately $11.77.

How much money does Electromed make?

Electromed (NYSEAMERICAN:ELMD) has a market capitalization of $100.75 million and generates $41.66 million in revenue each year. The medical equipment provider earns $2.31 million in net income (profit) each year or $0.28 on an earnings per share basis.

How many employees does Electromed have?

The company employs 132 workers across the globe.

How can I contact Electromed?

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The official website for the company is smartvest.com. The medical equipment provider can be reached via phone at (952) 758-9299, via email at investorrelations@electromed.com, or via fax at 866-758-5077.

This page (NYSEAMERICAN:ELMD) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -